Cargando…
Association of oesophageal radiation dose volume metrics, neutropenia and acute radiation oesophagitis in patients receiving chemoradiotherapy for non-small cell lung cancer
INTRODUCTION: The relationship between oesophageal radiation dose volume metrics and dysphagia in patients having chemoradiation (CRT) for non-small cell lung cancer (NSCLC) is well established. There is also some evidence that neutropenia is a factor contributing to the severity of oesophagitis. We...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4750212/ https://www.ncbi.nlm.nih.gov/pubmed/26864559 http://dx.doi.org/10.1186/s13014-016-0596-8 |
_version_ | 1782415399007027200 |
---|---|
author | Everitt, Sarah Duffy, Mary Bressel, Mathias McInnes, Belinda Russell, Christine Sevitt, Tim Ball, David |
author_facet | Everitt, Sarah Duffy, Mary Bressel, Mathias McInnes, Belinda Russell, Christine Sevitt, Tim Ball, David |
author_sort | Everitt, Sarah |
collection | PubMed |
description | INTRODUCTION: The relationship between oesophageal radiation dose volume metrics and dysphagia in patients having chemoradiation (CRT) for non-small cell lung cancer (NSCLC) is well established. There is also some evidence that neutropenia is a factor contributing to the severity of oesophagitis. We retrospectively analysed acute radiation oesophagitis (ARO) rates and severity in patients with NSCLC who received concurrent chemotherapy and high dose radiation therapy (CRT). We investigated if there was an association between grade of ARO, neutropenia and radiation dose volume metrics. MATERIAL AND METHODS: Patients with NSCLC having concurrent CRT who had RT dose and toxicity data available were eligible. Exclusion criteria included previous thoracic RT, treatment interruptions and non-standard dose regimens. RT dosimetrics included maximum and mean oesophageal dose, oesophagus dose volume and length data. RESULTS: Fifty four patients were eligible for analysis. 42 (78 %) patients received 60 Gy. Forty four (81 %) patients received carboplatin based chemotherapy. Forty eight (89 %) patients experienced ARO ≥ grade 1 (95 % CI: 78 % to 95 %). ARO grade was associated with mean dose (r(s) = 0.27, p = 0.049), V20 (r(s) = 0.31, p = 0.024) and whole oesophageal circumference receiving 20 Gy (r(s) = 0.32 p = 0.019). In patients who received these doses, V20 (n = 51, r(s) = 0.36, p = 0.011), V35 (n = 43, r(s) = 0.34, p = 0.027) and V60 (n = 25, r(s) = 0.59, P = 0.002) were associated with RO grade. Eleven of 25 (44 %) patients with ARO ≥ grade 2 also had ≥ grade 2 acute neutropenia compared with 5 of 29 (17 %) patients with RO grade 0 or 1 (p = 0.035). CONCLUSION: In addition to oesophageal dose-volume metrics, neutropenia may also be a risk factor for higher grades of ARO. |
format | Online Article Text |
id | pubmed-4750212 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-47502122016-02-12 Association of oesophageal radiation dose volume metrics, neutropenia and acute radiation oesophagitis in patients receiving chemoradiotherapy for non-small cell lung cancer Everitt, Sarah Duffy, Mary Bressel, Mathias McInnes, Belinda Russell, Christine Sevitt, Tim Ball, David Radiat Oncol Research INTRODUCTION: The relationship between oesophageal radiation dose volume metrics and dysphagia in patients having chemoradiation (CRT) for non-small cell lung cancer (NSCLC) is well established. There is also some evidence that neutropenia is a factor contributing to the severity of oesophagitis. We retrospectively analysed acute radiation oesophagitis (ARO) rates and severity in patients with NSCLC who received concurrent chemotherapy and high dose radiation therapy (CRT). We investigated if there was an association between grade of ARO, neutropenia and radiation dose volume metrics. MATERIAL AND METHODS: Patients with NSCLC having concurrent CRT who had RT dose and toxicity data available were eligible. Exclusion criteria included previous thoracic RT, treatment interruptions and non-standard dose regimens. RT dosimetrics included maximum and mean oesophageal dose, oesophagus dose volume and length data. RESULTS: Fifty four patients were eligible for analysis. 42 (78 %) patients received 60 Gy. Forty four (81 %) patients received carboplatin based chemotherapy. Forty eight (89 %) patients experienced ARO ≥ grade 1 (95 % CI: 78 % to 95 %). ARO grade was associated with mean dose (r(s) = 0.27, p = 0.049), V20 (r(s) = 0.31, p = 0.024) and whole oesophageal circumference receiving 20 Gy (r(s) = 0.32 p = 0.019). In patients who received these doses, V20 (n = 51, r(s) = 0.36, p = 0.011), V35 (n = 43, r(s) = 0.34, p = 0.027) and V60 (n = 25, r(s) = 0.59, P = 0.002) were associated with RO grade. Eleven of 25 (44 %) patients with ARO ≥ grade 2 also had ≥ grade 2 acute neutropenia compared with 5 of 29 (17 %) patients with RO grade 0 or 1 (p = 0.035). CONCLUSION: In addition to oesophageal dose-volume metrics, neutropenia may also be a risk factor for higher grades of ARO. BioMed Central 2016-02-11 /pmc/articles/PMC4750212/ /pubmed/26864559 http://dx.doi.org/10.1186/s13014-016-0596-8 Text en © Everitt et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Everitt, Sarah Duffy, Mary Bressel, Mathias McInnes, Belinda Russell, Christine Sevitt, Tim Ball, David Association of oesophageal radiation dose volume metrics, neutropenia and acute radiation oesophagitis in patients receiving chemoradiotherapy for non-small cell lung cancer |
title | Association of oesophageal radiation dose volume metrics, neutropenia and acute radiation oesophagitis in patients receiving chemoradiotherapy for non-small cell lung cancer |
title_full | Association of oesophageal radiation dose volume metrics, neutropenia and acute radiation oesophagitis in patients receiving chemoradiotherapy for non-small cell lung cancer |
title_fullStr | Association of oesophageal radiation dose volume metrics, neutropenia and acute radiation oesophagitis in patients receiving chemoradiotherapy for non-small cell lung cancer |
title_full_unstemmed | Association of oesophageal radiation dose volume metrics, neutropenia and acute radiation oesophagitis in patients receiving chemoradiotherapy for non-small cell lung cancer |
title_short | Association of oesophageal radiation dose volume metrics, neutropenia and acute radiation oesophagitis in patients receiving chemoradiotherapy for non-small cell lung cancer |
title_sort | association of oesophageal radiation dose volume metrics, neutropenia and acute radiation oesophagitis in patients receiving chemoradiotherapy for non-small cell lung cancer |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4750212/ https://www.ncbi.nlm.nih.gov/pubmed/26864559 http://dx.doi.org/10.1186/s13014-016-0596-8 |
work_keys_str_mv | AT everittsarah associationofoesophagealradiationdosevolumemetricsneutropeniaandacuteradiationoesophagitisinpatientsreceivingchemoradiotherapyfornonsmallcelllungcancer AT duffymary associationofoesophagealradiationdosevolumemetricsneutropeniaandacuteradiationoesophagitisinpatientsreceivingchemoradiotherapyfornonsmallcelllungcancer AT bresselmathias associationofoesophagealradiationdosevolumemetricsneutropeniaandacuteradiationoesophagitisinpatientsreceivingchemoradiotherapyfornonsmallcelllungcancer AT mcinnesbelinda associationofoesophagealradiationdosevolumemetricsneutropeniaandacuteradiationoesophagitisinpatientsreceivingchemoradiotherapyfornonsmallcelllungcancer AT russellchristine associationofoesophagealradiationdosevolumemetricsneutropeniaandacuteradiationoesophagitisinpatientsreceivingchemoradiotherapyfornonsmallcelllungcancer AT sevitttim associationofoesophagealradiationdosevolumemetricsneutropeniaandacuteradiationoesophagitisinpatientsreceivingchemoradiotherapyfornonsmallcelllungcancer AT balldavid associationofoesophagealradiationdosevolumemetricsneutropeniaandacuteradiationoesophagitisinpatientsreceivingchemoradiotherapyfornonsmallcelllungcancer |